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The polycystic kidney disease (PKD1) gene-encoded protein, polycystin-1, is developmentally regulated, with highest expression levels
seen in normal developing kidneys, where it is distributed in a punctate pattern at the basal surface of ureteric bud epithelia. Overexpression
in ureteric epithelial cell membranes of an inhibitory pMyr-GFP-PKD1 fusion protein via a retroviral (VVC) delivery system and
microinjection into the ureteric bud lumen of embryonic day 11 mouse metanephric kidneys resulted in disrupted branching morphogenesis.
Using confocal quantitative analysis, significant reductions were measured in the numbers of ureteric bud branch points and tips, as well as in
the total ureteric bud length, volume and area, while significant increases were seen as dilations of the terminal branches, where significant
increases in outer diameter and volumes were measured. Microinjection of an activating 5TM-GFP-PKD1 fusion protein had an opposite
effect and showed significant increases in ureteric bud length and area. These are the first studies to experimentally manipulate polycystin-1
expression by transduction in the embryonic mouse kidney and suggest that polycystin-1 plays a critical role in the regulation of epithelial
morphogenesis during renal development.
D 2005 Elsevier Inc. All rights reserved.Keywords: Polycystic kidney disease; Polycystin-1; Kidney; Development; Ureteric bud; Branching morphogenesis; Viral transduction; Epithelial cell
adhesion; Migration; Focal adhesionIntroduction
The mammalian kidney derives from intermediate
mesoderm cells that migrate caudally to form the nephric
(Wolffian) duct, giving rise to a non-functional pronephros,
a transiently functional mesonephros and the permanent
metanephros. At embryonic day 10.5 in mice and day 28 in
man, the ureteric bud appears as an outgrowth of the
posterior portion of the nephric duct that then migrates and
invades the undifferentiated metanephric mesenchyme,
where reciprocal interactions lead to iterative rounds of
ureteric bud branching and elongation, as well as mesen-
chymal condensation and nephron induction at the tips. The
process of branching morphogenesis is controlled by a
variety of soluble growth factors and insoluble matrix0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.06.034
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E-mail address: pat.wilson@mssm.edu (P.D. Wilson).proteins via interactions with their receptors. These include:
glial-derived neurotrophic factor (GDNF) that signals via c-
Ret and GFRa1, as well as fibroblast growth factors, such as
FGF-7, that activate diverse FGF receptors. Other receptor-
dependent signaling pathways that have been implicated in
branching morphogenesis in the kidney include those
activated by bone morphogenetic protein (BMP) 7, activin,
wnts 2b, 7 and 11, pleiotrophin, midkine, laminin-5 and
fibronectin (reviewed in Burrow, 2000; Davies, 2002;
Piscione and Rosenblum, 2002; Vainio and Lin, 2002).
Strict regulation, coordination and integration of multiple
pathways are essential for the appropriate development and
differentiation of the normal metanephric kidney. Several
human diseases result in a cystic kidney phenotype after
genetic disruption of the ureteric bud branching process
including: renal coloboma syndrome, Townes–Brock syn-
drome, branchio-otorenal syndrome, Beckwith–Wiedemann
syndrome, Zellweger syndrome, Alagille syndrome and286 (2005) 16 – 30
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blum, 2002).
Autosomal dominant polycystic kidney disease (ADPKD)
is a very common progressive renal disease affecting 1:800
humans and is caused by mutations in the PKD1 gene in 85%
of cases. Loss of function of the PKD1-encoded polycystin-1
protein in heterozygous human patients results in the
formation of multiple tubular epithelial cysts, derived from
every segment of the nephron, that enlarge progressively and
eventually obliterate renal structure and function. The
pathophysiological changes leading to disease result from
abnormal persistent proliferation and lumenal fluid secretion
associated with apical membrane mispolarization of epider-
mal growth factor receptor and NaK-ATPase as well as
alterations in matrix receptors and adhesion properties
(Wilson, 1996).
Several lines of evidence suggest that ADPKD is of
developmental origin. Mutant mice, with a variety of
homozygous targeted disruptions in the PKD1 gene, develop
enlarged cystic kidneys and die in utero or perinatally, either
of renal or vascular malformations (Boulter et al., 2001; Kim
et al., 2000; Lu et al., 1997). This may also be true in humans
since no human patients homozygous for PKD1 mutations
have been identified, suggesting embryonic lethality. In
some heterozygous ADPKD patients, multiple renal cysts
have been detected in utero, even though symptoms of renal
insufficiency and hypertension may not develop until
adulthood (MacDermot et al., 1998; Sedman et al., 1987).
Furthermore, some fetal genes and proteins, including the h2
subunit of NaK-ATPase, the ErbB2 variant of EGF receptor
and the transcription factors Pax-2 and WT-1, fail to be
appropriately down-regulated after birth in ADPKD kidneys.
Abnormalities associated with persistent expression of these
fetal proteins are thought to contribute to the increased cell
proliferation and fluid transport defects in ADPKD cysts
(Ostrom et al., 2000; Wilson, 1996, 2004b; Wilson et al.,
2000).
Normal polycystin-1 is a large developmentally regulated
membrane protein, highly expressed in the human and
mouse kidneys, where it is localized to ureteric bud and
collecting tubule cell membranes. Low levels of expression
are seen in medullary collecting tubules in normal adult
kidneys (Geng et al., 1997; Van Adelsberg et al., 1997;
Ward et al., 1996; Wilson, 1997; Wilson et al., 1999).
Polycystin-1 can interact with extracellular matrix proteins
via its large, multidomain, extracellular N-terminal portion,
and it forms multiprotein complexes with focal adhesion
proteins and cell–cell adherens junction proteins. The
intracellular C-terminal portion of polycystin-1 has been
shown to initiate intracellular signaling via phosphorylation
and G protein activation, leading to transcriptional regu-
lation of differentiation-related genes (Arnould et al., 1998;
Bycroft et al., 1999; Geng et al., 2000; Kim et al., 1999; Li
et al., 1999; Malhas et al., 2002; Parnell et al., 1998; Weston
et al., 2001). Transduction and expression of C-terminal
domain polycystin-1 fusion proteins in various renal celllines also showed a membrane-associated pattern of
distribution and co-localization with the focal adhesion
protein, paxillin (Kaletta et al., 2003). In addition, over-
expression of full-length normal polycystin-1 has been
shown to induce tubulogenesis and migration in a renal cell
line cultured in collagen gels (Boletta et al., 2000; Nickel et
al., 2002). By contrast, human ADPKD epithelia, with
PKD1 mutations, have aberrantly increased adhesiveness to
extracellular collagen and show decreased motility. This
suggested that inhibition of polycystin-1 function might
cause increased matrix adhesion and decreased motility in
ureteric bud epithelia in vivo and thus cause abnormalities
in renal morphogenesis.
Focal adhesion complexes are structural anchorage sites
that normally form at discrete regions of the basal plasma-
membrane at points of contact between the cell and its
extracellular matrix. The recruitment, via integrins, of a
variety of specific kinases, phosphatases, Ras superfamily
proteins and adaptor molecules provides a signaling com-
plex that initiates intracellular signaling and provides a link
between the matrix and the actin cytoskeleton. Mutations in
other focal adhesion proteins, including tensin and neph-
rocystin, also lead to polycystic kidney diseases (Benzing et
al., 2001; Lo et al., 1994).
Here, we identify a role for polycystin-1 in the regulation
of normal renal development and morphogenesis in embry-
onic mouse kidneys in organ culture. This is the first study to
utilize experimental manipulation and analysis of the effects
of polycystin in this complex system that allows detailed
quantitative analysis of renal epithelial differentiation in the
context of normal 3-dimensional, multicellular interactions.
High levels of endogenous polycystin-1 were detected in
matrix-associated focal adhesion complexes in the basal
membrane of the ureteric bud from the onset of metanephric
development. Microinjection of a lentivral construct encod-
ing an inhibitory pMyr-GFP-C-terminal domain polycystin-
1 fusion protein into the developing ureteric bud signifi-
cantly decreased ureteric bud elongation and branching
morphogenesis and also significantly increased tubule
diameter and volume. By contrast, microinjection of an
activating 5TM-GFP-polycystin-1 fusion protein increased
ureteric bud elongation. Together with the demonstrated
increases in matrix adherence, deficiencies in focal adhesion
form and function as well as decreased migration capacities
of ADPKD epithelia, these studies suggest that polycystin-1
plays a critical role in the regulation of early ureteric bud
elongation, branching and tubule volume control during
morphogenesis of the developing metanephric kidney.Materials and methods
Human kidney tissues and cell lines
Human kidneys were perfused in situ and procured under
sterile conditions (National Disease Research Interchange,
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ately prior to microdissection and tissue culture of renal
tubule segments (Wilson et al., 1985); fixation in 4% fresh
paraformaldehyde (EM Sciences, Hatfield, PA) in phos-
phate-buffered saline (PBS), pH 7.4 for immunolocalization
and in situ hybridization studies or flash freezing in liquid
nitrogen and storage at 86-C for protein extraction. All
kidneys were checked for normal morphology by hematox-
ylin and eosin staining prior to use. Characterized, primary
and conditionally immortalized cultures derived from
microdissected normal human fetal collecting tubule
(HFCT) and normal adult collecting tubule (NHCT) were
generated and characterized as previously described (Racu-
sen et al., 1995; Wilson, 2004a). HEK 293 and HeLa cell
lines were obtained commercially (American Type Culture
Collection).
Antibodies, fusion proteins and expression constructs
A previously characterized monospecific polyclonal
antibody, raised in rabbits against a 31 peptide sequence
of the human polycystin-1 protein intracellular terminal
portion (residues 4169–4191) (Wilson et al., 1999), was
used at 1:500 or 1:1000 for immunostaining of tissue
sections or cell cultures and at 1:12,500 for Western
immunoblots. A mouse monoclonal anti-calbindin antibody
(Sigma, Clone D28K, 1:200 dilution), a rabbit anti-GFP
antibody (Molecular Probes at 1:250 dilution), a rabbit anti-
WT1 antibody (#C19, Santa Cruz 1:100) and a fluorescein
isothiocyanate (FITC)-conjugated peanut lectin (PNA) were
used to stain whole mount mouse fetal kidneys.
A human PKD1 C-terminal domain (CTD) fusion protein
was prepared for E. coli expression by PCR of a 0.6 kb
DNA fragment encoding amino acids 4105–4303 and
subcloning into the pET30 LIC (Novagen) vector which
encodes an in frame N-terminal His tag and S-tag, as
previously described (Li et al., 1999). For mammalian
expression and transfection analysis, the expression plasmid
pMyr-EGFP-PKD1-CTD, which encodes a GFP-polycystin-
1 fusion protein with an N-terminal myristoylation signal
sequence (the pp60v-src sequence MGSSKSKPKDPSQRR),
was used as described previously (Li et al., 1999; Kaletta et
al., 2003) as well as a PKD1-5TM mammalian expression
vector which encodes a pre-pro-trypsin GFP-polycystin-1
fusion protein with 5 transmembrane domains as well as the
CTD (Kaletta et al., 2003).
For ureteric bud microinjections and long-term mam-
malian expression, a pMyr-EGFP-PKD1-CTD expression
construct was generated using the VVC self-inactivating
lentivirus (E. Federova and G.L Gusella, manuscript in
preparation). The VVC lentivector was derived from the
substitution of the U3 region of the 5VLTR of pHR/CMV
vector with the human early cytomegalovirus promoter.
From the resulting vector, the U3 region of the 3V-LTR
was subsequently deleted to obtain the self-inactivating
lentiviral vector VVC. In VVC, the expression of the viralfull-length genomic RNA, required during viral produc-
tion, is driven by the CMV promoter. The Xho1–BamH1
fragments encoding the pMyr-EGFP-PKD1-CTD fusion
protein were ligated into the VVC vector polylinker site,
and the expression and titers of the PKD1-CTD constructs
were tested on cultured HeLa-Tat cells. Infectious viral
supernatants with a titer of >1  107 Transducing Units
(TU)/ml were produced by transient transfection of 293T
cells using Lipofectamine 2000 (Life Technologies). 8 Ag
of VVC-pMyr-EGFP-PKD1-CTD was co-transfected with
5.0 Ag of the pCMVDR8.2 plasmid producing the viral
proteins and 2.5 Ag of the pMDG plasmid expressing the
pseudotyping VSV glycoprotein (VSVG) (Naldini et al.,
1996). After 24 h, the medium was replaced with complete
medium supplemented with 4 mM sodium butyrate, and
supernatants were collected 48 h later. After filtration
through a 0.45 Am filter, the virus was concentrated by
centrifugation for 5 h at 30,000  g, and the pellets were
resuspended. The titer (TU/ml) was determined 48 h after
infection of 3  104 HeLa-Tat cells/well in 24-well plates
by scoring the number of EGFP expressing cells using UV
microscopy.
Immunohistochemistry and fluorescence staining
Tissue sections of 4 h paraformaldehyde-fixed human
tissue, and monolayer cultures of 10 min paraformaldehyde-
fixed, 0.1% Triton X-100 permeabilized human renal
epithelia, were incubated in 0.3% H2O2 in methanol to
block endogenous peroxidase activity followed by 10%
normal goat or rabbit serum in PBS, prior to 45 min
incubation in primary antibody diluted 2% BSA/PBS. After
3 washes of 5 min each in PBS–Tween 20 (0.02%), sections
or cells were incubated for 45 min each with biotinylated
goat anti-rabbit IgG and avidin–biotin peroxidase (Vectas-
tain Elite, Vector Laboratories), with 3 intervening washes
in PBS–Tween. After 2 washes in Tris-buffered saline
(TBS), color development was carried out for 15 min using
amino-ethylcarbazole as substrate. Cells or tissue sections
were then washed in distilled water, coverslips mounted
with Aquapolymount (Polysciences) and viewed under a
Nikon FXA-Microphot microscope equipped with Nomar-
ski optics. Each of 5 replicate experiments was conducted
on a single day under identical conditions and consisted of
25 sections comprising a developmental series of normal
kidneys and age-matched ADPKD kidneys from 6 different
donors. Filter-grown fetal mouse kidney rudiments were
fixed for 15 min in 100% methanol at 20-C and subjected
to immunofluorescence after 2 h incubation at 37-C with
anti-calbindin, anti-WT-1 or anti-GFP antibodies diluted
1:200, 1:100 and 1:250, respectively, in PBS–5% FBS.
After 2 rinses in PBS–Tween and 1 in PBS for 10 min, the
secondary antibodies, donkey anti-mouse–Alexa 488 or
donkey anti-rabbit–Alexa 568 (Molecular Probes), were
used in 1:250 dilution, and incubation was carried out for
2 h at 37-C. After 3 washes in PBS, some kidneys were
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anti-rabbit Tyramide amplification kit, 1:100) according to
the manufacturer’s instructions, for 15 min at room
temperature, washed three times in PBS and then stored
in the dark until examination by confocal microscopy.
In situ hybridization
Tissue sections of normal human fetal and adult kidneys
that had been fixed in 4% fresh paraformaldehyde prepared
in DEPC-treated PBS and embedded in low temperature
wax were mounted on silanized Probe-On Plus slides
(Fisher, Springfield, NJ), deparaffinized and subjected to
digoxigenin–anti-digoxigenin in situ hybridization analysis
as described previously (Wilson et al., 2000). The PKD1-
CTD probe (the coding region for amino acids 4169–4191)
was generated by PCR prior to digoxigenin substitution.
Each of 5 replicate experiments was conducted on a single
day and conducted under identical conditions, consisted of
25 sections comprising a developmental series of normal
kidneys and age-matched ADPKD kidneys from 6 different
donors.
Luciferase reporter transcription assays
HEK 293 cells were co-transfected with pMyr-EGFP-
PKD1-CTD and a reporter vector containing the 5V-flanking
region of the prolactin gene linked to the firefly luciferase
reporter gene (pCRE-Luc, Stratagene) and an unrelated
plasmid DNA used to keep the amount of DNA in each
sample constant. In additional studies, 293 cells were
transfected with the PKD1-5TM alone (Kaletta et al.,
2003) or together with the pMyr-EGFP-PKD1-CTD. Cell
lysates were collected 24 h after transfection, and luciferase
activities were determined using a luminometer. Positive
controls were carried out by co-transfection of pFC-MEKK
plasmid with pCRE-Luc and negative controls by co-
transfection of the empty vector with pCRE-Luc. All values
were expressed as mean T SEM for 2 separate transfection
experiments, each conducted in triplicate.
Adhesion assays
Equal numbers of normal CT and ADPKD cells were
suspended by treatment with collagenase and plated onto
type I collagen-coated plastic surfaces in multiwell cluster
plates. After 4 h, unattached cells were removed by
aspiration, and the numbers of attached cells remaining on
the plate quantified by the colorimetric MTS assay (Cell
Titer Aq, Promega) followed by microdensitometry.
Migration assays
A modified Boyden chamber assay (Fluoroblock system;
Falcon) was employed followed by microfluorimetric anal-
ysis on an automated plate reader. Equal numbers of NHCTand ADPKD cells were suspended and preloaded with the
non-toxic fluorescent indicator calcein AM, prior to plating
5000 cells in the upper chamber of a Falcon HTS insert (8 AM
filter membrane pore size) in a well of a 24-multiwell cluster
plate and in the presence of a growth factor (serum) gradient
of 1% (in the upper chamber) to 5% (in the lower chamber).
Fluorescence was detected only in cells that migrated through
the membrane into the lower medium compartment.
Mouse metanephric embryonic fetal kidney organ culture
and microinjection
Embryonic day (E) 11.5–12.5 kidneys were retrieved
from timed pregnant CD-1 mice (Charles Rivers Laborato-
ries, Wilmington, MA), and paired kidneys were harvested
by microdissection using a dissecting stereomicroscope
equipped with a Scion computer imaging system (Olympus).
Kidneys were placed on uncoated 24 mm Transwell Clear
membrane inserts, 0.4 Am pore size, in a 6-well cluster
(Corning Incorporated, Corning NY), and 1ml supplemented
serum-free organ culture media containing 50% DMEM,
50% Ham F12; 15 mM HEPES and l-glutamine (Cellgro,
Mediatech, VA) 4.5 g/l glucose, 45 mM sodium bicarbonate,
1 insulin/transferrin/selenium (ITS, Sigma), 2  109 TI3,
7  108 M prostaglandin E1 (Avner et al., 1985; Ekblom et
al., 1983; Vilar et al., 1996) was added to the lower chamber
of each well. Plates were placed into a tissue culture incubator
(5% CO2) for up to 5 days with daily media changes.
For the microinjections, sterile transfer tips with 15 Am
internal diameter (ES, Eppendorf, Hamburg, Germany) were
used. On day zero, an Eppendorf micromanipulator 5171
and transjector 5246 were used to inject 20–200 nl of 107
particles per ml stock of the VVC-pMyr-EGFP-PKD1-CTD
VSV pseudotyped packaged viral particles; VVC alone
(empty vector); or PBS (sham) into the ureteric bud of
E11.5–12.5 mouse kidneys.
Microscopy and data analysis
Morphological changes were documented daily using an
Olympus dissecting microscope, equipped with Scion
computer imaging system. Immunofluorescence analysis
was carried out using a laser scanning confocal microscope
with inverted configuration using immersion lenses (BioRad
Radiance 2000, MSSM-Microscopy Shared Research
Facility).
Image J analysis (NIH), an open domain Java image
processing system, was used to calculate area and pixel
value statistics, to measure distances and volumes and to
create skeletonized images.
Statistics
Means, standard deviations and standard errors of the
mean were determined in sets of paired PKD1 vector-
treated versus control, empty vector-treated kidneys form
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t test was used to compare each parameter measured and P
values determined, P < 0.05 were considered statistically
significant.Results
Developmental regulation of polycystin-1 in focal
complexes of human mesonephric and metanephric kidneys
Using our previously characterized anti-human polycys-
tin-1 C-terminal domain antibody (Wilson et al., 1999) and
Figs. 1A and B), immunoblot analysis showed high levels of
polycystin-1 expression in early human fetal metanephric
kidneys (12–16 weeks) and low levels in adult kidneys
(32–59 years) (Fig. 1C). Similarly, conditionally immortal-
ized epithelial cell cultures derived from normal micro-
dissected human fetal collecting tubules (HFCT) showed
high levels of polycystin-1 expression, while similar
cultures derived from normal adult collecting tubules
(NHCT) showed lower levels of expression (Fig. 1D).
In situ hybridization (Figs. 2A, B) and immunohisto-
chemistry confirmed and extended these findings, showingFig. 1. Western immunoblot analysis of polycystin-1 in human kidney tissues and c
was prepared using the PET32 Novagen vector which encodes an in-frame coding
tag fusion protein (lanes 1 and 2), whereas pre-immune controls do not (lanes 3 an
E. coli induction with IPTG (arrowhead, left panel) as well as a >460 kDa protein
cell line (star, right panel). (C) Western immunoblot analysis shows that polycysti
human fetal kidney tissues: 12 weeks gestation (lane 1), 16 weeks gestation (lane 2
lower band shows actin, a loading control. (D) Western immunoblot of polycys
epithelial cell lines. Lanes 1 and 2: normal fetal collecting tubule (HFCT) lines; lan
an actin loading control.high levels of ureteric bud mRNA expression and strong
punctate staining for polycystin-1 at the basal membranes of
the developing ureteric bud-derived collecting duct epithe-
lium. This was particularly marked in the inner truncal
portions of the ureteric bud (Figs. 2E, F, L). By contrast, in
normal human adult kidneys, low levels of expression were
seen only in the medulla (Fig. 2D versus C; H versus G),
where light immunostaining for polycystin-1 was mostly
restricted to the apical/lateral membranes of inner medullary
collecting ducts (Fig. 2H, arrowheads). To determine the
stage of onset of renal polycystin-1 expression, first trimester
kidneys were examined (Figs. 2I–L). Strong focal staining
for polycystin-1 was seen on the basal membranes of
mesonephric ducts (Fig. 2I) and in the ureteric bud at the
earliest stages of metanephric kidney development (Fig. 2J).
By the time of its first bifurcation (Fig. 2K), a punctate
pattern of staining was seen at the basal membrane regions of
the ureteric bud epithelium, and this localization was
maintained throughout the second trimester (Figs. 2H and L).
A similar strong focal pattern of endogenous polycystin-
1 staining was demonstrated by immunocytochemical and
immunofluorescent analysis of subconfluent HFCT cells
after attachment to type I collagen in vitro (Fig. 3A, x/y
plane; Fig. 3B, x/z plane). In confluent monolayers,ell lines. (A) PKD1 C-terminal domain fusion protein for E. coli expression
sequence for S-tag. The polycystin-1 antiserum (1:12,500) recognizes the S-
d 4). (B) The polycystin-1 antiserum recognizes its S-tag fusion protein after
in cell lysates prepared from a normal human fetal collecting tubule (HFCT)
n-1 (>460 kDa) is developmentally regulated with high levels expressed in
) and low levels in adult kidneys of 16 years (lane 3); 49 years (lane 4). The
tin-1 (>460 kDa) in differentiated conditionally immortalized human renal
es 3 and 4: normal adult collecting tubule (NHCT) lines. The lower band is
Fig. 2. In situ hybridization and (A–D) and immunohistochemical (E–L) analysis of polycystin-1 and PKD1 in human kidneys. (A) Human fetal kidney, 8
weeks of gestation. In situ hybridization showing PKD1 mRNA in ureteric bud epithelia with particularly intense staining in the truncal stalk portions. (B)
Human fetal kidney of 16 weeks gestation. PKD1 mRNA is detected in the medullary region of the developing ureteric bud. (C) Human adult kidney, 27 years:
no PKD1 mRNA is seen in the cortical region. (D) Human adult kidney, 27 years: PKD1 mRNA is detected in inner medullary collecting ducts and urothelium.
Each in situ hybridization experiment, comparing fetal and adult kidneys, was carried out simultaneously. Four separate experiments were conducted. (E)
Human fetal kidney of 8 weeks gestation. The polycystin-1 antiserum (1:500) detects punctate staining at the basal surface of the epithelial cells of the
branching ureteric bud (arrows) with most staining in the truncal stalk portions deep in the medulla. Note the absence of staining in immature glomerulus (G) or
S body (S). (F) Human fetal kidney of 16 weeks gestation. Basal staining is seen in the medullary region of the ureteric bud. (G) Human adult kidney, 27 years.
No staining is seen in the cortex of normal adult kidney. (H) Human adult kidney, 27 years. Light staining is seen at the apico-lateral junctions (arrowheads) of
inner medullary collecting ducts. Each immunohistochemistry experiment, comparing fetal and adult kidneys, was carried out simultaneously. Four separate
experiments were conducted. (I) Human mesonephric kidney of 6 weeks gestation: Punctate focal localization of polycystin-1 is seen in the basal membranes of
the mesonephric duct epithelium. (J) Human metanephric kidney of 6 weeks gestation: Polycystin-1 is detected in the epithelial ureteric bud outgrowth, while
the surrounding metanephric blastema is unstained. (K) Human metanephric kidney of 8 weeks gestation. Punctate polycystin-1 staining is seen at the basal
membrane of the ureteric bud epithelium undergoing its first bifurcation. (L) Human metanephric kidney of 13 weeks gestation: Basal polycystin-1 staining is
seen in the truncal stalk portion of ureteric bud.
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fluorescent staining that is consistent with basolateral
membrane localization (Fig. 3C). This pattern of staining
was consistent with previous studies showing polycystin-1
recruitment to multiprotein complexes within focal adhesion
plaques (Wilson et al., 1999) and with the focal patterns of
polycystin-1 and tensin staining in mouse embryonic
kidneys (Geng et al., 1997; Lo et al., 1994). Of importance
for the subsequent microinjection analysis, similar patterns
of GFP fluorescence were seen after transfection of pMyr-
EGFP-PKD1-CTD or 5TM-EGFP-PKD1 into renal epithe-
lia in vitro (Figs. 3D–F).
Defects of adhesion and migration in polycystic kidney
disease epithelia
Our previous studies had shown that primary cultures of
ADPKD cyst lining epithelia were more adherent to
extracellular collagen matrices than cultured cells derivedfrom age-matched normal renal tubule epithelia (Wilson et
al., 1996, 1999). Increased adhesion to type I collagen
matrix was also characteristic of conditionally immortalized
human ADPKD epithelia by comparison to normal adult
collecting tubule (NHCT) cells in culture (Fig. 3G). In
addition, as might be predicted, ADPKD epithelia showed a
markedly reduced ability to migrate in response to a growth
factor gradient by comparison to NHCT (Fig. 3H).
Overexpression of a pMyr-EGFP-C-terminal domain
polycystin-1 fusion protein, which inhibits
polycystin-1-mediated activation of AP-1, inhibits ureteric
bud branching morphogenesis
In studies of AP-1 activation conducted in 293 cells,
transfections with the PKD1-TM5 plasmid (encoding amino
acid residues 3871–4303 of polycystin-1) activated AP-1 as
shown by a luciferase reporter minigene assay (Fig. 4). Co-
transfection of the pMyr-EGFP-PKD1-CTD construct, but
Fig. 3. Focal adhesion localization of endogenous and transfected polycystin-1 in human renal epithelial cell lines. (A) Immunoperoxidase staining of a
subconfluent normal human fetal collecting tubule (HFCT) epithelial cell, showing high power image of punctate staining consistent with focal adhesion
localization (anti-polycystin-1 antibody 1:1000; x/y plane). (B) Immunofluorescent localization of polycystin-1 in a subconfluent HFCT cell showing punctate
staining at the basal surface of the cell consistent with focal adhesion localization (anti-polycystin-1 antibody 1:1000; x/z plane). (C) Immunonofluorescent
staining of confluent HFCT cells showing a lower power image and a chicken-wire pattern consistent with basolateral cell membrane localization (anti-
polycystin-1 antibody 1:1000; x/y plane). (D) GFP fluorescence of pMyr-EGFP-PKD1-CTD distribution in a single HEK 293 cells, 48 h after transfection.
Punctate staining at the cell periphery is seen. (E) GFP fluorescence of pMyr-EGFP-PKD1-CTD distribution in a single LLC-PK1 cell 48 h after transfection.
Punctate staining at the cell membrane is seen. (F) GFP fluorescence of 5TM-EGFP-PKD1 distribution in 293 cells 48 h after transfection. Staining is seen at
the cell membrane. (G) After 4 h of adhesion to type I collagen matrix, significantly more ADPKD epithelia adhere than age-matched normal collecting tubule
(NHCT) epithelia. 5000 cells were plated per well. (H) A modified Boyden chamber assay of migration of cells in response to a 1–5% growth factor gradient
showed that far fewer ADPKD epithelial migrated through the filters than normal age-matched NHCT cells.
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activation produced by transfection with PKD1-TM5 (Fig.
4). We then developed a lentiviral vector encoding the same
pMyr-EGFP-CTD-polycystin-1 fusion protein (see Materi-
als and methods) which inhibited polycystin-1-dependent
AP-1 activation and delivered this viral vector by micro-
injection (20 nl of 107 particles/ml) into the ureteric bud
lumens of E11.5/12.5 normal mouse embryonic kidneys in
organ culture (Fig. 5). Expression was monitored daily by
examination of GFP fluorescence and shown throughout the
structure of the developing ureteric bud (Fig. 5D), where it
demonstrated a membrane pattern of staining (Fig. 5E).
Phase contrast microscopy of untreated normal mouse
embryonic kidney organ cultures after 1, 2, 3 and 4 daysof culture showed increased organ size and complexity of
morphogenesis. Injection of PBS (sham) or VVC vector
lacking the pMyr-EGFP-PKD1-CTD insert (‘‘empty vector’’)
showed similar degrees of development as the untreated
control over 4 days in organ culture. After microinjection of
the inactivating VVC-pMyr-EGFP-PKD1-CTD into mouse
kidney ureteric buds on day zero, however, a decrease in size
and reduction in complexity of differentiation were observed
after 4 days in culture (Fig. 6).
Comparative qualitative and quantitative analyses of
ureteric bud branching were carried out on pairs of
embryonic kidneys from multiple animals. Whole mount
kidney rudiments were stained by immunofluorescence with
antibodies against the ureteric bud constituent protein,
Fig. 4. The pMyr-PKD1-C terminal domain construct inhibits polycystin-1-mediated activation of AP-1. HEK 293 cells were co-transfected with AP-1-LUC
and empty vector (negative control) or AP-1-LUC together with different PKD1 constructs. It is seen that overexpression of the PKD1-5TM construct activated
AP-1 and stimulated the 7X AP-1 promoter element (bars 7 and 8), while co-expression of the pMyr-EGFP-PKD1-CTD inhibited the activation of AP-1
mediated by PKD1-5TM (bars 11 and 12).
Fig. 5. Microinjected pMyr-EGFP-PKD1-CTD constructs transduce the whole ureteric bud of mouse embryonic kidneys in organ culture. (A) The VVC-pMyr-
EGFP-PKD1-CTD self-inactivating lentiviral construct was titered on HeLa-TAT cells and microinjected (0.11 Ag/ml; 5 Al) into the lumens of developing
ureteric buds of E11/E12 mouse embryonic kidneys on day 0 of organ culture. (B) Schematic of injection protocol. (C) No fluorescence was seen in uninjected
mouse embryonic kidneys in organ culture after 3 days. (D) Delivery and expression of the construct throughout the developing ureteric bud were demonstrated
by GFP fluorescence seen here after 3 days of organ culture. (E) A high power image of the boxed portion in panel D shows expression of the pMyr-EGFP-
PKD1-CTD at the basal cell membrane as indicated by the chicken-wire pattern of localization.
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Fig. 6. Transduction of pMyr-EGFP-PKD1-CTD in the ureteric bud inhibits development of mouse embryonic kidneys in organ culture. Phase contrast
microscopy of control uninjected; sham-injected with PBS; or empty. VVC vector-injected E12 mouse embryonic kidneys after 1, 2, 3 and 4 days of organ
culture show a regular and equal increase in organ size and complexity of morphogenesis. By contrast, VVC-pMyr-EGFP-PKD1-CTD-injected kidneys
showed little increase in size or complexity after day 1 of organ culture.
K. Polgar et al. / Developmental Biology 286 (2005) 16–3024calbindin, after 3 days of organ culture (Fig. 7). Confocal
microscopy showed distinct differences in patterns of ureteric
bud branching morphogenesis in the VVC-pMyr-EGFP-
PKD1-CTD-treated kidneys versus paired matched controlsFig. 7. Transduction of pMyr-EGFP-PKD1-CTD disrupts ureteric bud morphog
confocal analysis of calbindin distribution in VVC-pMyr-EGFP-PKD1-CTD vers
days of subsequent organ culture (anti-calbindin antibody 1:200; upper panel). Pat
show regular branching patterns in control kidneys but stunted and irregula
Quantitative analysis of multiple pairs of kidneys showed that transduction of the
and ureteric bud volume, reduced numbers of ureteric bud branch points and branc
were significant resultant increases in the outer diameters of the bud at the initial d
particularly marked increases in volumes of the terminal branches. Multiple paired
(n = 11 pairs). Reduced numbers of branch tips (n = 9 pairs). Reduced ureteric bud
diameters of the first branch points (n = 10 pairs). Increased terminal branch
glomerular induction. FITC peanut agglutinin lectin (PNA) fluorescence analysis
versus empty VVC (control)-injected kidneys after 3 days of subsequent organ cul
transduction of pMyr-EGFP-PKD1-CTD in the ureteric bud (n = 12 pairs).injected with empty vector (Fig. 7, upper panel). Kidneys
microinjected with lentiviral pMyr-EGFP-PKD1-CTD
showed disorganized and stunted patterns of ureteric bud
branching and apparent widening of the terminal branches.enesis and glomerular induction. Whole mount immunofluorescence and
us empty VVC (control)-injected E11.5 mouse embryonic kidneys after 3
terns of fluorescent staining as well as Image J-derived skeletonized images
r branching patterns in VVC-pMyr-EGFP-PKD1-CTD-injected kidneys.
pMyr-EGFP-PKD1-CTD construct was associated with decreases in kidney
h tips and reductions in ureteric bud length and total area. Of note, however,
ivision of the ureteric bud stalk within the metanephric mesenchyme and the
sets of injected kidneys were quantified: Reduced numbers of branch points
length (n = 8 pairs). Reduced ureteric bud area (n = 5 pairs). Increased outer
volume (n = 10 pairs). Transduction of pMyr-EGFP-PKD1-CTD reduces
of glomerular development (lower panel) in VVC-pMyr-EGFP-PKD1-CTD
ture showed that significantly fewer glomeruli were induced in kidneys after
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Fig. 8. Transduction of 5TM-EGFP-PKD1-CTD enhances ureteric bud morphogenesis. Whole mount phase contrast, immunofluorescence and confocal
analysis of calbindin distribution in 5TM-EGFP-PKD1 versus control injected E11.5 mouse embryonic kidneys as in Fig. 7. Skeletonized imaging and
quantitative analysis of paired kidneys showed increases in kidney volume and ureteric bud elongation and glomerular induction (n = 5 pairs).
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K. Polgar et al. / Developmental Biology 286 (2005) 16–30 27Quantitative analysis confirmed a decrease in overall
kidney volume and a dramatic reduction in total ureteric bud
volume. Additional analyses of multiple paired sets of kid-
neys showed that ureteric bud transduction with VVC-pMyr-
EGFP-PKD1-CTD resulted in statistically significant reduc-
tions in the numbers of ureteric bud branch points and branch
tips (20.2 T 1.88 versus 6.18 T 0.64, P < 0.001, n = 11 pairs
and 27.67 T 3.6 versus 9.78 T 0.85, P < 0.002, n = 9 pairs,
respectively) as well as reduced ureteric bud length and
ureteric bud area (5677.3 T 1016.5 A versus 1305.41 T
152.64 A, P < 0.008, n = 8 pairs and 21.4 T 1.8 mm2 versus
6.44 T 0.38 mm2, P < 0.001, n = 5 pairs, respectively). By
contrast, transduction with VVC-pMyr-EGFP-PKD1-CTD
resulted in modest but statistically significant increases in the
outer diameter of the ureteric bud at the initial branch point
within the metanephric mesenchyme (52.35 T 1.85 A versus
64.71 T 2.96 A, P < 0.025, n = 10 pairs) and produced sub-
stantial statistically significant increases in the volume of the
ureteric bud at the terminal branch points (13.4 T 1.73 mm3
versus 36.67 T 8.29 mm3, P < 0.036, n = 10 pairs; Fig. 7).
Overexpression of pMyr-EGFP-PKD-1-CTD inhibits
glomerular induction
Whole mount staining with peanut agglutinin lectin
(PNA) or anti-WT-1 C19 antibody was used to detect
glomeruli in paired kidneys injected with VVC-pMyr-
EGFP-PKD1-CTD versus empty VVC alone (Fig. 7, lower
panel, PNA). Statistically significant reductions in glomer-
ular induction were detected after ureteric bud transduction
with VVC-pMyr-EGFP-PKD1-CTD (26.5 T 2.28 versus
5.17 T 0.97, P = 0.001, n = 12; Fig. 7).
Overexpression of a 5TM-polycystin-1 fusion protein, which
increases polycystin-1 activation of AP-1, increases ureteric
bud elongation
An identical set of studies was carried out to evaluate the
effects of microinjection of an activating 5TM-EGFP-PKD1
fusion protein into E11.5 fetal mouse kidneys. Fig. 8 shows
the effects after 4 days in culture. Phase microscopy
suggested that transduction with 5TM-EGFP-PKD1 caused
a slight increase in size, and this was confirmed by
quantitative analysis as a trend but did not reach statistical
significance. Calbindin staining and confocal analysis of
ureteric bud development as well as glomerular induction
showed trends towards increases in most parameters and
reached statistical significance with regard to increases in
ureteric bud length and ureteric bud area. By contrast, the
outer diameters of the first branch points tended to decrease.Discussion
Several lines of evidence had led to the suggestion that
PKD1-encoded protein, polycystin-1, might play an essen-tial developmental role in the morphogenesis of the
mammalian kidney. PKD1 knockout mice are embryonic
or perinatal lethal with cystic kidney development, and
many fetal genes are aberrantly expressed in the kidneys of
mice and humans with PKD. Initial antibody studies showed
high levels of polycystin-1 expression in fetal mouse and
human kidneys predominantly localized to the basal plasma-
membranes of the ureteric bud-derived collecting duct
epithelia, in punctate focal deposits, consistent with focal
adhesions (Geng et al., 1997; Ward et al., 1996; Wilson,
1997). In addition, transfection of full-length PKD1 into
MDCK cells or activating PKD1 constructs into mouse
inner medullary collecting duct (IMCD) cells resulted in
altered cell morphology and tubulogenesis when grown in
3-dimensional collagen gels (Boletta et al., 2000; Nickel et
al., 2002).
Subsequent biochemical, cellular, molecular and genetic
analysis supported the conclusion that polycystin-1 acts as a
mechanosensor in contact with the extracellular environ-
ment at three sites in mammalian renal tubule epithelial
cells: at the basal membrane in focal adhesion complexes at
the cell–matrix interface (Wilson, 1997; Wilson et al.,
1999), in the apico-lateral cell adherens junctions at the
cell–cell interface (Huan and van Adelsberg, 1999) and at
the apical central primary cilium membrane at the cell–
lumen interface (Yoder et al., 2002). Signals from the
environment received by the long, extracellular, multi-
domain N-terminal of polycystin-1 are coordinated by
means of multiprotein complex formation and local cation
fluxes at the membrane and then transduced via phosphor-
ylation and protein–protein interactions at the intracellular
C-terminal portion of polycystin-1 resulting in initiation of
intracellular signaling cascades and regulation of gene
transcription (Wilson, 2004b).
The current study is the first to utilize the intact mouse
embryonic kidney in organ culture to analyze directly the
effects of inhibition of PKD1 gene transduction. Similar to
the mouse, normal polycystin-1 expression is maximal
during metanephric kidney development and is also
predominantly localized to the basal membrane focal
adhesions of the developing ureteric bud in a punctate
pattern consistent with in vivo focal adhesions. Interestingly,
this localization is seen as early as in the mesonephric duct
as well as after the first bifurcation of the metanephric
ureteric bud. This localization persists through mid-gestation
and contrasts with the lower levels of expression and
predominantly apical–lateral localization of polycystin-1 in
normal post-natal and adult kidney collecting tubule
epithelia. Polycystin-1 also rapidly localizes to basal
membrane focal adhesion structures of subconfluent cultures
of human fetal collecting tubule epithelia after attachment to
exogenous collagen, where it has previously been shown to
co-localize, co-sediment and co-immunoprecipitate with
several focal adhesion complex proteins including paxillin,
vinculin, talin, a-actinin, focal adhesion kinase, c-src and
p130cas (Geng et al., 2000; Wilson et al., 1999). In addition,
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localization with the focal adhesion index protein, paxillin,
indicates focal adhesion targeting of polycystin-1 in renal
epithelia transfected with either the AP-1 activating, 5TM-
PKD1 or the pMyr-EGFP-PKD1-CTD expression constructs
which block polycystin-1-dependent AP-1 activation (Kaletta
et al., 2003). The ability of polycystin-1 to modify its
preponderance of distribution in response to different cellular
conditions has also been suggested by its apical–lateral
pattern of distribution in confluent normal renal tubule
cultures and co-localization, co-sedimentation and co-immu-
noprecipitation with cell–cell adherens junction proteins
including E-cadherin h-, a- and g-catenins (Charron et al.,
2000; Geng et al., 2000). Ciliary staining has also been
detected in fully differentiated confluent renal epithelial
cultures, but not in subconfluent cultures (Nauli et al., 2003,
and R. Rohatgi personal communication).
The early onset of expression of polycystin-1 in the
metanephric kidney and its concentration in the focal
adhesion points of contact between the basal cell membrane
and the extracellular matrix in the deeper stalk portions of
the trunk of the ureteric bud suggested a role for polycystin-
1 in the migration and elongation of the ureteric bud during
branching morphogenesis. This hypothesis was further
suggested by evidence that ADPKD epithelia have marked
defects in cell–matrix interactions including a significantly
decreased migratory capacity and increased adherence to
collagen matrix proteins. Cell–matrix abnormalities have
long been known to be characteristic of ADPKD epithelia in
vitro, where they contribute to the abnormal epithelial cell
proliferation rates and altered apical–basal polarization of
ADPKD epithelia (Carone and Kanwar, 1993; Roitbak et
al., 2004; Wilson et al., 1991, 1992).
Since polycystin-1 is highly expressed in the ureteric bud
of fetal kidneys and AP-1 activation has been implicated as
an important polycystin-1 downstream signaling pathway
(Kim et al., 1999), we sought to determine whether its
inactivation might influence the regulation of renal develop-
ment. To this end, we engineered a pMyr-EGFP-PKD1-
CTD fusion protein that interferes with the activation of AP-
1 by PKD1-TM5 and used a lentiviral delivery vector to
determine whether inactivation of polycystin-1 signaling
had a direct effect on ureteric bud morphogenesis in the
embryonic mouse metanephric kidney in organ culture. The
presence of a myristoylation signal sequence ensured
insertion of the transduced polycystin-1 protein into the
basal cell membrane of the ureteric bud, and injection at
early stages of ureteric bud proliferation ensured expression
throughout the developing tree. The ‘‘chicken-wire’’ appear-
ance of GFP staining confirmed that the transduced protein
was targeted to the basal membrane of the ureteric bud,
where it would be in the same location as endogenous
polycystin-1 and thus able to exert its inactivating (possibly
dominant negative) effect. We speculate that this effect
might be brought about through competition with protein–
protein interactions and/or by inactivating polycystin-1-induced intracellular signaling cascades including those that
act through JNK kinase/MAP kinase/AP-1 pathways as
implicated by Kim et al. (1999) and known to often be
involved with cell proliferation, differentiation and morpho-
genesis (Davis, 1999; Reed et al., 2001). Although sham
injections or injection of empty lentiviral vector alone had
no effect on the progressive elaboration of ureteric bud
branching and nephron induction in vitro, the injection of
dominant negative pMyr-EGFP-PKD1-CTD dramatically
reduced but did not eliminate ureteric bud branching and
glomerular induction. Detailed quantitative analysis also
showed significantly expanded diameters of the ureteric bud
at the initial T-shaped bifurcations within the metanephric
mesenchyme as well as at the tips. Since our construct
targets the basal membrane focal adhesions, this suggests
that inactivation of polycystin-1 at this site has effects on
ureteric bud elongation, branching, volume and diameter
control. By contrast, the injection of activating 5TM-EGFP-
PKD1 caused opposite effects, leading to statistically
significant increases in ureteric bud elongation, consistent
with the findings of Boletta et al. (2000) showing that
polycystin-1 induced tubulogenesis in MDCK cells in col-
lagen gels.
Although these findings do not rule out important
functional roles for apical and lateral polycystin-1, they do
suggest a primary role for basal polycystin-1 in early
metanephric developmental branching morphogenesis. The
predominant localization at cell–cell junctions in normal
adult kidney epithelia as well defects in polycystin-1–
cadherin-complex formation and polarity abnormalities in
ADPKD epithelia suggest a critical role for apical–lateral
polycystin-1, seen predominantly in adult kidneys, in the
maintenance of the differentiated state (Charron et al., 2000;
Roitbak et al., 2004). By contrast, recent studies are con-
sistent with a role for apical ciliary polycystin-1 (possibly
in concert with the autosomal recessive polycystic kidney
disease (ARPKD) gene product fibrocystin) in the response
to luminal ion concentration and fluid flow, suggesting
a possible role in tubule maturation which predominates
in the perinatal/pediatric periods (Nauli et al., 2003; Rohatgi
et al., 2003).
The formation and dynamic turnover of focal adhesion
complexes are essential for normal cell migration involving
matrix attachment at the apical pole and detachment at the
posterior pole (Laukaitis et al., 2001). Recent work has
shown that paxillin, a marker component of the polycystin-
1-containing focal adhesion complex, is also characteristic
of dynamic apical adhesions essential for FAK-dependent
migration (Webb et al., 2002). This is consistent with
mutations in PKD1 leading to defective recruitment and
phosphorylation of FAK into ADPKD focal adhesions
(Wilson et al., 1999). Not surprisingly, mutations in many
genes whose products are involved in focal adhesion
assembly and function have also been implicated to play
important roles in the control of migration: including FAK,
p130cas, c-src and protein tyrosine phosphatases (Angers-
K. Polgar et al. / Developmental Biology 286 (2005) 16–30 29Loustau et al., 1999; Cary et al., 1998; Ilic et al., 1995;
Verbeek et al., 1999) and to have impact on cell polarity
(Timpson et al., 2001). Taken together, this suggests that the
over-adherent, sluggishly motile phenotype of ADPKD
epithelia is a consequence of functionally defective cell–
matrix interactions via the focal adhesions and leads to
stunted ureteric bud elongation and branching. Maintenance
of the integrity of the focal adhesion complex during
development of the ureteric bud is critical, as suggested by
evidence that mutations in other genes, such as tensin and
NPH1, whose protein products are integral components of
the focal adhesion that interact with actin and p130cas, also
cause cystic kidney disease (Benzing et al., 2001; Geng et
al., 1997).
The essential features of normal branching morpho-
genesis require coordination of epithelia cell proliferation
and migration to bring about appropriate elongation of the
bud, the precise temporal and spatial regulation of branch-
ing, as well as strict control of the bud volume and internal
and external diameters. We conclude that interference with
polycystin-1 signaling pathways may interfere with regu-
lation of the early stages of branching morphogenesis of the
metanephric kidney. This is apparently a common genetic
target for mutations frequently associated with renal cyst
formation in human diseases.Acknowledgments
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